Assembly Biosciences ASMB Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $72.3M+154% | $28.52M+298% | $7.16M— | $0— | ||
| $64.81M+15.9% | $55.93M+14.4% | $48.9M-30.1% | $69.98M+2.1% | ||
| $19.61M+8.9% | $18.01M-21.4% | $22.91M-5.1% | $24.13M-16.1% | ||
| $84.42M+14.2% | $73.94M+3.0% | $71.81M-23.7% | $94.11M-32.3% | ||
| —— | -$45.42M+29.7% | -$64.65M+31.3% | -$94.11M+29.1% | ||
| $6M+7.6% | $5.57M+61.5% | $3.45M+238% | $1.02M+238% | ||
| —— | -$40.18M+34.4% | -$61.23M+34.2% | -$93.09M+28.3% | ||
| —— | -$6.72+49.9% | -$13.40+42.0% | -$23.09-665% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
